A biopharmaceutical company focused on the development, in-licensing,acquisition and eventual commercialization of multiple complementary products and product candidates within franchises that target rare diseases.
Lead Underwriter
BofA Merrill Lynch,Stifel Nicolaus & Company, Incorporated
Co-Managers
Arctic Securities AS,JMP Securities LLC,Roth Capital Partners, Inc